2m 2m 2m 2m 2m 2m 2m
MODERNA (MRNA)
NASDAQ
$62.39+$3.05 (+5.13%)
Price as of Jun 23, 2026 1:50 PM EDT- $23.5BMarket Cap
- 131.18%1-Year Change
- BiotechnologyIndustry
MODERNA (MRNA)
$62.39+$3.05 (+5.13%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 1.8B -43.82% | 3.2B -52.75% | 6.8B -64.45% | 19.3B +4.29% | |
Cost of Revenue | 868.0M -40.71% | 1.5B -68.80% | 4.7B -13.35% | 5.4B +106.95% | |
Gross Profit | 950.0M -46.39% | 1.8B -17.77% | 2.2B -84.44% | 13.8B -12.66% | |
Sales and Marketing Expense | 133.0M -8.90% | 146.0M -28.43% | 204.0M N/A | N/A N/A | |
Research and Development Expense | -3.1B -31.06% | -4.5B -6.23% | -4.8B +47.04% | -3.3B +65.49% | |
Depreciation and Amortization Expense | 215.0M +13.76% | 189.0M -69.57% | 621.0M +78.45% | 348.0M +50.00% | |
Total Operating Expenses | 5.0B -30.12% | 7.2B -35.23% | 11.1B +12.64% | 9.8B +90.20% | |
Operating Profit | -3.1B -22.08% | -3.9B -6.94% | -4.2B -145.00% | 9.4B -29.15% | |
Interest Income | 314.0M -26.12% | 425.0M +0.95% | 421.0M +110.50% | 200.0M +1,011.11% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 314.0M -26.12% | 425.0M +0.95% | 421.0M +110.50% | 200.0M +1,011.11% | |
Total Nonoperating Income and Expense | -8.0M -90.80% | -87.0M -29.84% | -124.0M +175.56% | -45.0M +55.17% | |
Income before Taxes | -2.8B -23.26% | -3.6B -8.50% | -3.9B -141.17% | 9.6B -27.93% | |
Income Taxes | 54.0M +217.39% | -46.0M -105.96% | 772.0M -36.36% | 1.2B +12.00% | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -2.8B -20.75% | -3.6B -24.46% | -4.7B -156.37% | 8.4B -31.47% | |
Net Income from Continuing Operations Applicable to Common | -2.8B -23.26% | -3.6B -8.50% | -3.9B -141.17% | 9.6B -27.93% | |
Basic EPS and Net Income | -7.26 -21.77% | -9.28 -24.74% | -12.33 -158.00% | 21.26 -29.86% | |
Diluted EPS and Net Income | -7.26 -21.77% | -9.28 -24.74% | -12.33 -161.28% | 20.12 -28.88% | |
Basic Weighted Average Shares | 389.0M +1.30% | 384.0M +0.52% | 382.0M -3.05% | 394.0M -2.23% | |
Diluted Weighted Average Shares | 389.0M +1.30% | 384.0M +0.52% | 382.0M -8.17% | 416.0M -3.48% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 2.6B +34.67% | 1.9B -33.71% | 2.9B -9.30% | 3.2B -53.20% | |
Short-Term Investments | 3.2B -37.15% | 5.1B -10.51% | 5.7B -14.93% | 6.7B +72.65% | |
Cash and Cash Equivalents and Short-Term Investments | 5.8B -17.45% | 7.0B -18.35% | 8.6B -13.11% | 9.9B -7.69% | |
Total Current Assets | 6.5B -19.20% | 8.1B -21.56% | 10.3B -23.13% | 13.4B -16.43% | |
Accumulated Depreciation | 737.0M +39.85% | 527.0M +21.71% | 433.0M -34.19% | 658.0M +86.93% | |
Property and Plant and Equipment and Net | 2.1B -2.82% | 2.2B +12.90% | 1.9B -3.62% | 2.0B +62.61% | |
Total Long-Term Assets | 605.0M +1.85% | 594.0M -13.28% | 685.0M -30.67% | 988.0M +2,805.88% | |
Total Assets | 12.3B -12.76% | 14.1B -23.25% | 18.4B -28.74% | 25.9B +4.82% | |
Income Taxes Payable | 249.0M +6.41% | 234.0M +271.43% | 63.0M +31.25% | 48.0M -94.52% | |
Total Short-Term Debt | 1.0B N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.0B -9.93% | 2.2B -26.83% | 3.0B -38.76% | 4.9B -46.07% | |
Total Long-Term Debt | 590.0M N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 285.0M +6.74% | 267.0M +4.30% | 256.0M +89.63% | 135.0M +77.63% | |
Total Liabilities | 3.7B +13.79% | 3.2B -29.11% | 4.6B -32.12% | 6.7B -36.00% | |
Retained Earnings | 7.2B -28.09% | 10.0B -26.17% | 13.6B -25.73% | 18.3B +83.97% | |
Total Stockholders Equity | 8.7B -20.65% | 10.9B -21.32% | 13.9B -27.55% | 19.1B +35.19% | |
Total Shares Outstanding | 394.0M +2.07% | 386.0M +1.05% | 382.0M -0.78% | 385.0M -4.47% | |
Cash Flow | |||||
Cash from Operating Activities | -1.9B -37.65% | -3.0B -3.66% | -3.1B -162.60% | 5.0B -63.43% | |
Capital Expenditures | 192.0M -81.73% | 1.1B +48.66% | 707.0M +76.75% | 400.0M +40.85% | |
Cash from Investing Activities | 1.9B -0.15% | 1.9B -53.66% | 4.2B +181.26% | -5.2B -39.27% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 593.0M +958.93% | 56.0M +104.07% | -1.4B -60.06% | -3.4B +294.96% | |
Financials Ratio | |||||
Gross Margin | 52.26% -4.57% | 54.76% +74.01% | 31.47% -56.22% | 71.88% -16.25% | |
Operating Margin | -169.09% +38.70% | -121.91% +96.94% | -61.90% -226.58% | 48.90% -32.06% | |
Return on Assets | -21.31% -2.53% | -21.87% +2.72% | -21.29% -164.32% | 33.10% -56.59% | |
Return on Equity | -28.87% +0.34% | -28.77% +0.63% | -28.59% -156.87% | 50.27% -65.59% | |
Revenue Growth | -43.82% -16.92% | -52.75% -18.16% | -64.45% -1,603.10% | 4.29% -99.81% | |
Current Ratio | 3.29 -10.30% | 3.67 +7.21% | 3.42 +25.52% | 2.73 +54.96% | |
Cash Ratio | 1.31 +49.51% | 0.87 -9.41% | 0.96 +48.11% | 0.65 -13.22% | |
Debt-to-Equity Ratio | 0.18 N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | 0.13 N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow